Influence of a new hydroxyethylstarch preparation (HES 130/ 0.4) on coagulation in cardiac surgical patients.

Note that volumes of Gelatine and Starch required to maintain CVP are no different between two groups, suggesting that the two solutions are equally effective as plasma volume expanders. However, study has little statistical power with regards to volumes of fluids administered, blood loss or blood/blood product usage.

– M. Mythen.

Tagged bleeding, BLOOD-COAGULATION, cardiac, cardiopulmonary bypass, GELATIN, HES 130/0.4, hydroxyethylstarch, IN-VITRO, LACTATED RINGERS SOLUTION, MODIFIED THROMBOELASTOGRAPHY, STARCH, SURGERY, thromboelastography, VOLUME REPLACEMENT, VOLUME THERAPY

NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis

MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

SITEMAP

Contact us

Subscribe to our newsletter

Consent Management Platform by Real Cookie Banner

Influence of a new hydroxyethylstarch preparation (HES 130/ 0.4) on coagulation in cardiac surgical patients.

SITEMAP

Contact us

Follow us

Subscribe to our newsletter